Dr. Gordon leads business operations at Rion, including business development, commercialization, and marketing. He has a passion for commercializing innovative biopharmaceutical technologies to revolutionize disease treatment and improve patient outcomes. He brings over 20 years experience in commercial, technical, and manufacturing roles within the pharmaceutical industry. Previous to Rion, he led business and market development at StemoniX, commercializing the world’s first industrial-scale 3D human organoids for drug discovery and establishing numerous partnerships, and technical operations at Rebiotix, leading early CMC development of the most clinically advanced microbiota-based biologic drug under current investigation. He also served for over 13 years at 3M Drug Delivery Systems in product development, business development, account management, and operational leadership roles, including Global Business Manager of 3M’s transdermal components business. Dr. Gordon has contributed to numerous patents and has co-authored research publications related to stem cell applications in drug discovery and preclinical development, microbiome therapeutics, and transdermal drug delivery. Dr. Gordon earned a Ph.D. and B.S. in chemical engineering from the University of Minnesota and the University of Wisconsin-Madison, respectively. He is a certified Lean Six Sigma Black Belt and completed a mini MBA at the University of St. Thomas.